Advancing the evidence base in interventional cardiology
Crossref DOI link: https://doi.org/10.1038/s41569-018-0142-5
Published Online: 2018-12-19
Published Print: 2019-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Baumbach, Andreas http://orcid.org/0000-0001-7707-2254
Text and Data Mining valid from 2018-12-19
Article History
First Online: 19 December 2018
Competing interests
: A.B. has received consulting fees from Abbott Vascular, Cardinal Health and Microport, and speaker fees from Astra Zeneca.